# SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - Inspection Records

Source: https://www.keypedia.com/companies/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/184bcdd6-8f25-45bf-b562-fcb41f6c48f7

> Inspection records and compliance data for SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) in Dresden, None. Access full analysis and detailed observations.

---

## Details

- Name: SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
- FEI Number: 3004835618
- City: Dresden
- State: None
- Country Name: Germany
- Address Line 1: Zirkusstr. 40
- Zip Code: None

## Related Documents

- [483 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2024-03-15](https://www.keypedia.com/records/483/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/6f6c1e55-a46a-45bc-ba2a-765b5d67b78d) — source: FDA, date: March 15, 2024
- [483 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2024-03-15](https://www.keypedia.com/records/483/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/844c9c7a-b8f2-438a-8fe3-d89cb297cebc) — source: FDA, date: March 15, 2024
- [FDA Inspection 1233707 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2024-03-15](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/064ffa75-823f-4b4a-ac70-4da31c81faa0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2024
- [FDA Inspection 1181891 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2022-09-20](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/33ac34b8-0200-4357-bc2a-e2425a7a2bad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2022
- [FDA Inspection 1101506 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2019-07-05](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/63db143a-b785-4875-96d0-efc0ded378e0) — classification: No Action Indicated (NAI), source: FDA, date: July 5, 2019
- [FDA Inspection 1019795 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2017-06-27](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/e4847276-f3f0-4073-a7d2-e60f6d62c3c5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2017
- [FDA Inspection 736162 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2011-06-22](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/9bd6598d-06ea-4432-a764-dfef23c024fb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2011
- [FDA Inspection 668686 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2010-05-24](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/49014175-4fa2-49ea-bcf4-5a95e1454b0d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2010
- [FDA Inspection 584548 - SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) - 2009-04-30](https://www.keypedia.com/records/fda_inspections/smithkline-beecham-pharma-gmbh-co-kg-dba-glaxosmithkline-biologicals/8a8fa07d-e58b-4844-8e97-d62539570ab8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 30, 2009

## Related Companies

- [Galentic Pharma (India) Pvt. Ltd](https://www.keypedia.com/companies/galentic-pharma-india-pvt-ltd/b1a67f71-574b-402f-980d-14f817cf31ae)
- [Terumo BCT Ltd](https://www.keypedia.com/companies/terumo-bct-ltd/182a5d92-4c5c-4393-95cd-45250ca7eb25)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/37ed59ef-c570-47ec-8477-ca9c766cac29)
- [ENDO USA, Inc.](https://www.keypedia.com/companies/endo-usa-inc/f2df2e47-8303-4a2c-9881-5e2ecef64f22)
- [B. Braun Medical Inc](https://www.keypedia.com/companies/b-braun-medical-inc/7d193a37-e8a0-4f0f-aeea-f64ccd959191)
- [Fresenius Medical Care, North America](https://www.keypedia.com/companies/fresenius-medical-care-north-america/90cbe724-7310-49e8-983b-b062488d9710)
- [Fenwal International, Inc.](https://www.keypedia.com/companies/fenwal-international-inc/f7736da8-9a5b-421a-8f73-803b3504d456)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/0296844d-4369-423c-824a-f7d71344ec07)
- [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/f2814c8b-daff-42a4-abe2-59947a5bda3d)
- [Fresenius Medical Care de Mexico](https://www.keypedia.com/companies/fresenius-medical-care-de-mexico/a425662c-8722-4035-b4f4-5cf408ae88ac)

## Related Officers

- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Investigator](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)